Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine

Immunology and Microbiology

• Tumor Vaccine 50%
• Tumor Antigen 50%
• Tumor Immunity 50%
• Genetic Transfection 50%
• Cross Reacting Antigen 50%
• Major Histocompatibility Complex 50%

Biochemistry, Genetics and Molecular Biology

• Ovalbumin 100%
• Tumor Antigen 50%
• Tumor Immunity 50%
• Transfection 50%